FDA Drug · D-0277-2026

TYLENOL a) 500 MG., 2'S DISPLAY, 50CT; b) COLD & FLU, 25CT/2S; c) COLD & FLU SEVERE, 2PK, 50CT; d) PM, 50CT; e) SINUS SEVERE, 2PK, 50CT

Class II · Ongoing

CGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center.

Affected lots / codes — check yours against thisAll lots within expiry distributed by Gold Star Distribution.

Recalling firm: GOLD STAR DISTRIBUTION INC, Minneapolis, MN
Classification: Class II (temporary or reversible harm possible)
Status: Ongoing
Quantity: —
Distribution: US Nationwide.
Recall initiated: December 26, 2025
Classified: January 14, 2026
Initiation: Voluntary: Firm initiated

Official source. This record is published by the U.S. FDA through the openFDA enforcement database. View the unmodified government record:
https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0277-2026%22

Important. Recalls target specific lots and codes — compare the affected lots above against your own product. This page reproduces public FDA data for readability; EveryRecall is independent and not affiliated with the FDA.

See every recall for this brand: Is GOLD STAR DISTRIBUTION INC recalled? →

Check this brand across all 8 databases →